Rainier Acquisition Corporation Class A Ordinary Shares

Rainier Acquisition Corporation Class A Ordinary Shares(RNAQ)の株式分析

$9.980

0.000 (0.00%)終値時点

Loading chart…
高値
9.980
始値
9.980
出来高加重平均価格
9.98
出来高
20.00
時価総額
—
安値
9.980
売買代金
199.60
EV/EBITDA(TTM)
0.00

Rainier Acquisition Corporation is a blank check company. The Company is formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses. The Company has not selected any business combination, has conducted no operations and has generated no revenues. It intends to focus on life sciences companies that apply biology to improve human health.

AI分析 of Rainier Acquisition Corporation Class A Ordinary Shares (RNAQ)

売り

Rainier Acquisition Corp (RNAQ) is not a good buy right now due to its low current ratio of 0.18, indicating potential liquidity issues, and a negative total equity of -7293.00 USD, which raises concerns about its financial health. Additionally, the stock is trading at a 52-week low of 9.90, which is only 13.3% of its 52-week range, suggesting it is underperforming. The RSI is at 38.423, indicating it is nearing oversold conditions but lacks a strong buy signal. The main risk is its total debt of 25000.00 USD against its low current assets of 17707.00 USD, which could lead to financial instability.

バリュエーション指標

Rainier Acquisition Corporation Class A Ordinary Shares(RNAQ)の現在の予想PERは0.00で、5年平均はです。

予想PER

5年平均 P/E
現在のP/E
0.00

予想EV/EBITDA

5年平均 EV/EBITDA
現在のEV/EBITDA
0.00

予想PSR

5年平均 P/S
現在のP/S
0.00

イベントタイムライン

2026-09-21 (ET)

16:00:00

Nscale Limited Files for IPO, Plans to List on NYSE

RNAQ のよくある質問 — Alphio AI が回答

Rainier Acquisition Corporation is a blank check company. The Company is formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses. The Company has not selected any business combination, has conducted no operations and has generated no revenues. It intends to focus on life sciences companies that apply biology to improve human health.

Rainier Acquisition Corp (RNAQ) is not a good buy right now due to its low current ratio of 0.18, indicating potential liquidity issues, and a negative total equity of -7293.00 USD, which raises concerns about its financial health. Additionally, the stock is trading at a 52-week low of 9.90, which is only 13.3% of its 52-week range, suggesting it is underperforming. The RSI is at 38.423, indicating it is nearing oversold conditions but lacks a strong buy signal. The main risk is its total debt of 25000.00 USD against its low current assets of 17707.00 USD, which could lead to financial instability.

コミュニティ

もっと見る ↗

投稿はまだありません

登録またはログインして議論に参加

関連記事

本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。

取引を始める